[go: up one dir, main page]

WO2003097008A3 - Transdermal delivery device for the administration of fentanyl - Google Patents

Transdermal delivery device for the administration of fentanyl Download PDF

Info

Publication number
WO2003097008A3
WO2003097008A3 PCT/GB2003/002120 GB0302120W WO03097008A3 WO 2003097008 A3 WO2003097008 A3 WO 2003097008A3 GB 0302120 W GB0302120 W GB 0302120W WO 03097008 A3 WO03097008 A3 WO 03097008A3
Authority
WO
WIPO (PCT)
Prior art keywords
fentanyl
administration
delivery device
transdermal delivery
irritant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2003/002120
Other languages
French (fr)
Other versions
WO2003097008A2 (en
Inventor
Francisco Jose Evarist Stefano
Alejandro Fabio Scasso
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
THALAS GROUP Inc
PAGET HUGH CHARLES EDWARD
Original Assignee
THALAS GROUP Inc
PAGET HUGH CHARLES EDWARD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ARP020101791A external-priority patent/AR033748A1/en
Priority claimed from GB0229836A external-priority patent/GB0229836D0/en
Application filed by THALAS GROUP Inc, PAGET HUGH CHARLES EDWARD filed Critical THALAS GROUP Inc
Priority to AU2003230034A priority Critical patent/AU2003230034A1/en
Publication of WO2003097008A2 publication Critical patent/WO2003097008A2/en
Publication of WO2003097008A3 publication Critical patent/WO2003097008A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A simple, non-irritant and chemically stable transdermal delivery device for the administration of fentanyl comprises a pressure sensitive acrylic adhesive matrix formed by a non-functional copolymer containing 2-5 % by weight of fentanyl, and lauryl alcohol as a permeation enhancer.
PCT/GB2003/002120 2002-05-15 2003-05-15 Transdermal delivery device for the administration of fentanyl Ceased WO2003097008A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003230034A AU2003230034A1 (en) 2002-05-15 2003-05-15 Transdermal delivery device for the administration of fentanyl

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AR020101791 2002-05-15
ARP020101791A AR033748A1 (en) 2002-05-15 2002-05-15 A DEVICE FOR THE TRANSDERMAL ADMINISTRATION OF PHARMACOLOGICALLY ACTIVE SUBSTANCES THAT INCLUDES TWO SUPERPOSED ADHESIVE LAYERS AND A PROCEDURE TO PREPARE IT
GB0229836A GB0229836D0 (en) 2002-12-20 2002-12-20 Transdermal delivery device for the administration of fentanyl
GB0229836.2 2002-12-20

Publications (2)

Publication Number Publication Date
WO2003097008A2 WO2003097008A2 (en) 2003-11-27
WO2003097008A3 true WO2003097008A3 (en) 2004-03-18

Family

ID=29550643

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2003/002120 Ceased WO2003097008A2 (en) 2002-05-15 2003-05-15 Transdermal delivery device for the administration of fentanyl

Country Status (2)

Country Link
AU (1) AU2003230034A1 (en)
WO (1) WO2003097008A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180263920A1 (en) * 2014-12-19 2018-09-20 3M Innovative Properties Company Transdermal drug delivery device including fentanyl
WO2022107182A1 (en) * 2020-11-18 2022-05-27 University Of Petra A composition of fentanyl and fatty acids, and a method of preparation thereof
CN112656778A (en) * 2020-12-28 2021-04-16 广东红珊瑚药业有限公司 Pressure-sensitive adhesive matrix and patch

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842662A1 (en) * 1996-05-13 1998-05-20 Hisamitsu Pharmaceutical Co., Inc. Percutaneous tape preparation containing fentanyl
WO2001026705A2 (en) * 1999-10-11 2001-04-19 Samyang Corporation A dual adhesive transdermal drug delivery system

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842662A1 (en) * 1996-05-13 1998-05-20 Hisamitsu Pharmaceutical Co., Inc. Percutaneous tape preparation containing fentanyl
WO2001026705A2 (en) * 1999-10-11 2001-04-19 Samyang Corporation A dual adhesive transdermal drug delivery system

Also Published As

Publication number Publication date
WO2003097008A2 (en) 2003-11-27
AU2003230034A1 (en) 2003-12-02
AU2003230034A8 (en) 2003-12-02

Similar Documents

Publication Publication Date Title
WO2001052823A3 (en) Compositions to effect the release profile in the transdermal administration of drugs
WO2004041324A3 (en) Transdermal delivery of fentanyl
AR097045A2 (en) TRANSDERMAL THERAPEUTIC SYSTEM
DK1183014T3 (en) Flavored controlled release oral pharmaceutical compositions
AU679032B2 (en) Transdermal therapeutic system with galanthamine as active ingredient
DK0781122T3 (en) Matrix for transdermal drug delivery
WO2003018075A3 (en) Transdermal therapeutic system with fentanyl or related substances
TW200514590A (en) Hydrophilic adhesives for delivery of herbal medicines
EP1623711A4 (en) External patch containing estrogen and/or progestogen
DE50214184D1 (en) TRANSDERMALES THERAPEUTIC SYSTEM (TTS) WITH THE ACTIVE FENTANYL
HRP20050828B1 (en) Uv stable transdermal therapeutic plaster
WO2006041911A3 (en) Device transdermal administration of drugs including acrylic polymers
TW200606476A (en) Polarizing plate
WO2002049622A3 (en) Transdermal system containing a novel high potency progestagen
WO2002030402A3 (en) Film for active ingredients dermal and transdermal administration
WO2002024157A3 (en) Acryl adhesive useful in transdermal drug delivery systems
EP1340797A3 (en) Aqueous dispersion type pressure-sensitive adhesive composition and pressure-sensitive adhesive product
DE502005006070D1 (en) COSMETIC FORMULATION ON MICROEMULSION BASE CONTAINING ALMOND ACID
WO2005117591A3 (en) Novel pharmaceutical formulation containing a biguanide and an angiotensin antagonist
BR0008640A (en) Transdermal delivery device
WO2006023644A3 (en) Transdermal drug delivery device with translucent protective film
WO2007050580A3 (en) Transdermal drug delivery system with acrylate or methacrylate functional pressure sensitive adhesive composition
WO2003097008A3 (en) Transdermal delivery device for the administration of fentanyl
CA2403949A1 (en) Transdermal therapeutic system for the delivery of lerisetron
WO2005046600A3 (en) Transdermal tulobuterol delivery

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP